Legato Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.82M	Buy	104,133 +7,542	+8%	+$132K	0.22%	130
2025 Q1	$1.22M	Buy	96,591 +75,130	+350%	+$945K	0.16%	199
2024 Q4	$226K	Sell	21,461 -2,891	-12%	-$30.5K	0.03%	517
2024 Q3	$353K	Buy	+24,352	New	+$353K	0.04%	487